Strategic Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,347
Closed -$202K 136
2024
Q4
$202K Sell
2,347
-52
-2% -$5.62K 0.01% 135
2024
Q3
$286K Hold
2,399
0.02% 116
2024
Q2
$342K Sell
2,399
-103
-4% -$13.6K 0.02% 102
2024
Q1
$321K Hold
2,502
0.02% 104
2023
Q4
$259K Hold
2,502
0.02% 110
2023
Q3
$228K Buy
+2,502
New +$220K 0.02% 113

Other funds holding NVO

Strategic Financial Services's NVO Position: Q1 2025 in Review

Strategic Financial Services sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,347 shares — an estimated $202K sold.

Strategic Financial Services first reported a position in NVO in Q3 2023 and held it in 6 quarters. The position peaked at $342K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Strategic Financial Services reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Strategic Financial Services sold 2,347 Novo Nordisk shares in Q1 2025, an estimated $202K.
  • Strategic Financial Services first reported a position in Novo Nordisk in Q3 2023 and held it in 6 quarters.
  • Strategic Financial Services's Novo Nordisk position peaked at $342K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Strategic Financial Services's 13F filing for Q1 2025, filed 23 May 2025.